[ Price : $8.95]
AdvaMed recommends ways to improve CDRHs voluntary medical device manufacturing and product quality program.[ Price : $8.95]
Federal Register notice: FDA announces the Web site location where it will post two lists of guidance documents that CDRH intends ...[ Price : $8.95]
Federal Register notice: FDA makes available a guidance entitled Product Name Placement, Size, and Prominence in Promotional Label...[ Price : $8.95]
FDA releases its latest batch of Warning Letters that includes Fagron Compounding Services, RC Outsourcing and Seindni Co.[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection extension for FDA Application for Participation in FDA Fe...[ Price : $8.95]
FDA posts a final guidance on Product Name Placement, Size, and Prominence in Promotional Labeling and Advertisements for drugs. ...[ Price : $8.95]
Janssen Research & Development submits a supplemental NDA for two new Xarelto (rivaroxaban) vascular indications: reducing the ris...[ Price : $8.95]
FDA says it will publish early next year a draft guidance outlining a voluntary, alternative pathway for demonstrating substantial...